Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 19, 2026, titled “Glenmark Pharmaceuticals Inc., USA launches Authorized Generic to Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg”. |SUBJECT: Press Release